IDEAYA Biosciences Inc (NAS:IDYA)
$ 30.98 -1 (-3.13%) Market Cap: 2.68 Bil Enterprise Value: 1.86 Bil PE Ratio: 0 PB Ratio: 2.27 GF Score: 28/100

IDEAYA Biosciences Inc At Barclays Lunchtime Fireside Chat Series Transcript

Dec 05, 2023 / 05:00PM GMT
Release Date Price: $31.43 (-3.02%)
Peter Lawson Barclays;Analyst

Great. Thanks. Good afternoon. My name is Pete Lawson and one of the biotech analysts at Barclays. So important to our lunchtime deep dive with Idea and color. These courses tend to look at catalysts adjacent to our coverage as well as an inside our coverage catalysts that we think are interesting to investors is the 3rd year that we do in these fireside chats focus of prefunding useful. And just wherever orientation is a 30-minute call. If you have questions, you can e-mail me directly. So that's peter dot lawson at barclays.com or you can give me call Bloomberg, and I'm just looking in the two gives me great pleasure to introduce the Harry Potter and the CEO and Founder of them.

Questions & Answers

Peter Lawson Barclays;Analyst

Well, I think the fundamental logic of the kind of the uveal and MAT2A and of course, also Park, which is kind of interesting, thanks to the story that's emerging. I'm maybe the first question would be just around the your R&D Day yesterday, kind of what you found interesting or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot